BNP Paribas Financial Markets Has $408,000 Holdings in Proto Labs, Inc. (NYSE:PRLB)

BNP Paribas Financial Markets trimmed its holdings in shares of Proto Labs, Inc. (NYSE:PRLB) by 65.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,908 shares of the industrial products company’s stock after selling 26,152 shares during the quarter. BNP Paribas Financial Markets owned about 0.06% of Proto Labs worth $408,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Assenagon Asset Management S.A. acquired a new position in shares of Proto Labs during the 2nd quarter valued at about $7,535,000. Bailard Inc. acquired a new stake in shares of Proto Labs in the second quarter worth $405,000. Panagora Asset Management Inc. boosted its holdings in shares of Proto Labs by 4.0% during the 2nd quarter. Panagora Asset Management Inc. now owns 168,033 shares of the industrial products company’s stock worth $5,191,000 after buying an additional 6,469 shares during the period. Innealta Capital LLC acquired a new position in Proto Labs in the 2nd quarter valued at $40,000. Finally, Quest Partners LLC raised its holdings in Proto Labs by 146.5% in the 2nd quarter. Quest Partners LLC now owns 30,403 shares of the industrial products company’s stock worth $939,000 after acquiring an additional 18,068 shares during the period. 84.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

PRLB has been the subject of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Proto Labs in a report on Friday, November 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $40.00 target price on shares of Proto Labs in a report on Monday, November 4th. Finally, Craig Hallum lifted their price target on Proto Labs from $30.00 to $36.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Proto Labs presently has an average rating of “Moderate Buy” and an average price target of $40.33.

Proto Labs Stock Performance

NYSE PRLB opened at $43.59 on Friday. Proto Labs, Inc. has a twelve month low of $25.75 and a twelve month high of $45.15. The stock has a market cap of $1.07 billion, a PE ratio of 46.37 and a beta of 1.45. The firm has a 50-day simple moving average of $35.58 and a 200 day simple moving average of $32.27.

Proto Labs (NYSE:PRLB) last released its quarterly earnings data on Friday, November 1st. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.15. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The business had revenue of $125.60 million for the quarter, compared to analysts’ expectations of $121.38 million. During the same period in the previous year, the business posted $0.31 earnings per share. Proto Labs’s quarterly revenue was down 3.9% on a year-over-year basis. Research analysts forecast that Proto Labs, Inc. will post 0.84 earnings per share for the current fiscal year.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.